O11 biomedical GmbH
EIC Accelerator Winner From 2023
RESPILIQ - enteral CO2 absorption for the therapy of hypercapnic lung failure
Germany
Articles
O11 Biomedical GmbH Secures EIC Accelerator Funding for Innovative Hypercapnia Treatment
GermanyEIC Accelerator2023
Read Article